Use of human reconstructed epidermis to analyze the regulation of beta-defensin hBD-1, hBD-2, and hBD-3 expression in response to LPS
2003
Cell Biol Toxicol 2003 Oct ;19 (5):313-24 | INSERM U346, affiliee CNRS, Peau Humaine et Immunite, Hopital Edouard Herriot, Lyon, France.
Ocular surface reconstruction using cultivated mucosal epithelial stem cells
2003
Cornea 2003 Oct ;22 (7 Suppl):S75-80 | Department of Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan. [email protected]
Carbohydrate expression and modification during keratinocyte differentiation in normal human and reconstructed epidermis
2003
Exp Dermatol 2003 Oct ;12 (5):537-45 | L'Oreal Recherche, Paris, France. [email protected]
The use of reconstructed human skin to evaluate UV-induced modifications and sunscreen efficacy
2003
Exp Dermatol 2003 ;12 Suppl 2):64-70 | Life Sciences Research, L'Oreal, Centre Charles Zviak, Clichy, France. [email protected]
In vitro reconstruction of human dermal equivalent enriched with endothelial cells
2003
Biomaterials 2003 Mar ;24 (7):1205-1211 | Univ Padua, Dept Histol Microbiol & Med Biotechnol, I-35121 Padua, Italy. Abatangelo, G, Univ Padua, Dept Histol Microbiol & Med Biotechnol, Viale G Colombo 3, I-35121 Padua, Italy.
A strategy for the development of tissue engineering scaffolds that regulate cell behavior
2003
Biomaterials 2003 Jun ;24 (13):2267-2275 | Natl Inst Agrobiol Sci, Lab Anim Cell Biol, Tsukuba, Ibaraki 3050901, Japan. Takezawa, T, Natl Inst Agrobiol Sci, Lab Anim Cell Biol, Ikenodai 2, Tsukuba, Ibaraki 3050901, Japan.
Reduced expression of the hyphal-independent Candida albicans proteinase genes SAP1 and SAP3 in the efg1 mutant is associated with attenuated virulence during infection of oral epithelium
2003
J Med Microbiol. 2003 Aug;52(Pt 8):623-32 | Department of Dermatology and Allergology, University of Munich, Munich, Germany.
LAV694, a new antiproliferative agent showing improved skin tolerability vs. clinical standards for the treatment of actinic keratosis
2003
Biochem Pharmacol. 2003 Nov 15;66(10):1885-95. | Preclinical Safety Department, Novartis Pharma AG, WSH.2881.P03, CH-4002 Basel, Switzerland.
Assessment of the skin photoprotective capacities of an organo-mineral broad-spectrum sunblock on two ex vivo skin models
2003
Photodermatol Photoimmunol Photomed. 2003 Oct;19(5):242-53. | Laboratoire des IMRCP, UMR 5623 au CNRS, Université Paul Sabatier, 118 route de Narbonne, 31062 Toulouse Cedex 04, France.
An assessment of the phototoxic hazard of a personal product ingredient using in vitro assays
2003
Toxicol In Vitro. 2003 Aug;17(4):471-80 | Safety and Environmental Assurance Centre, Unilever Colworth, MK44 1LQ, Sharnbrook, Bedfordshire, UK. [email protected]
The secreted aspartyl proteinases Sap1 and Sap2 cause tissue damage in an in vitro model of vaginal candidiasis based on reconstituted human vaginal epithelium
2003
Infect Immun. 2003 Jun;71(6):3227-34. | Department of Dermatology and Allergology, University of Munich, Germany. [email protected]
Albumin effects on drug absorption and metabolism in reconstructed epidermis and excised pig skin
2003
ALTEX. 2003;20(1):3-9. | Institut für Pharmazie, Pharmazie und Toxikologie, Freie Universität Berlin, D-Berlin.
Caspase-14 expression by epidermal keratinocytes is regulated by retinoids in a differentiation-associated manner
2002
J Invest Dermatol 2002 ;119 (5):1150-5 | Division of Immunology, Allergy, and Infectious Diseases, Department of Dermatology, University of Vienna Medical School, Austria.
Characterization of the living skin equivalent as a model of cutaneous re-epithelialization
2002
CELL BIOCHEM FUNCT. Cell Biochemistry and Function 2002 ;20 (2):129-141 | Prof. E.J. Wood, Sch. of Biochem./Molecular Biology, University of Leeds, Leeds LS2 9JT EML: [email protected]
Comparison of activities dependent on glutathione S-transferase and cytochrome P-450 IA1 in cultured keratinocytes and reconstructed epidermal models
2002
Skin Pharmacol Appl Skin Physiol 2002 ;15 Suppl 1):59-67 | Paul Gerson Unna-Skin Research Center, Beiersdorf AG, Hamburg, Germany.
Comparison of cutaneous bioavailability of cosmetic preparations containing caffeine or < alpha >-tocopherol applied on human skin models or human skin ex vivo at finite doses
2002
SKIN PHARMACOL APPL SKIN PHYSIOL. Skin Pharmacology and Applied Skin Physiology 2002 ;15 (Suppl. 1):40-58 | F. Dreher, L'Oreal Research, F-93601 Aulnay-sous-Bois EML: [email protected]
Comparison of gene expression profiles in human keratinocyte mono-layer cultures, reconstituted epidermis and normal human skin; transcriptional effects of retinoid treatments in reconstituted human epidermis
2002
Exp Dermatol 2002 ;11 (1):59-74 | BIOalternatives, Gencay, France. [email protected]
A computational skin model: fold and wrinkle formation
2002
IEEE Trans Inf Technol Biomed 2002 ;6 (4):317-23 | MIRAlab, University of Geneva, CH1211 Geneva, Switzerland. [email protected]
Development and in vitro characterisation of novel bioresorbable and bioactive composite materials based on polylactide foams and Bioglass for tissue engineering applications
2002
Biomaterials 2002 ;23 (18):3871-8 |
Epidermal-dermal interactions regulate gelatinase activity in ApligrafR, a tissue-engineered human skin equivalent
2002
BR J DERMATOL. British Journal of Dermatology 2002 ;146 (1):26-31 | Dr. P. Schmid, TA Immunopathology/Dermatology, Novartis Pharma Research, 4002 Basel EML: [email protected]